Filter
6219
Filtered Results: 6219
Text search:
World
Health
Organization
Africa
WHO
Featured
Recommendations
556
New Publications
1459
Language
Document type
No document type
3414
Studies & Reports
1254
Guidelines
666
Manuals
272
Strategic & Response Plan
216
Fact sheets
154
Training Material
93
Situation Updates
75
Online Courses
23
Infographics
19
Resource Platforms
17
Brochures
10
Videos
4
App
2
Countries / Regions
Global
296
South Africa
217
Kenya
208
Africa
191
Sierra Leone
172
Nigeria
164
Ethiopia
162
Liberia
157
Uganda
136
Zambia
110
Malawi
108
Middle East and North Africa
103
West and Central Africa
91
Rwanda
90
Tanzania
89
Ghana
87
India
86
Congo, Democratic Republic of
84
Mozambique
81
Syria
75
East and Southern Africa
75
South Sudan
67
Guinea
62
Western and Central Europe
60
Zimbabwe
55
Yemen
55
Lesotho
54
Senegal
50
Latin America and the Carribbean
50
Namibia
49
Nepal
48
Burkina Faso
41
Ukraine
36
Cameroon
35
Russia
35
Central African Republic
32
Bangladesh
31
Botswana
30
Angola
29
Asia
29
Myanmar / Burma
27
Sudan
26
South–East Asia Region
26
Benin
25
Eastern Europe
25
Eswatini/ Swaziland
23
Mali
22
Somalia
22
China
21
Brazil
21
Haiti
18
Cambodia
18
Indonesia
18
Madagascar
18
Guinea-Bissau
16
Côte d’Ivoire / Ivory Coast
15
Philippines
15
Afghanistan
15
Colombia
15
Pakistan
14
Chad
13
Germany
12
Eastern Europe and Central Asia
12
Southern Africa
11
Thailand
10
Vietnam
10
Iraq
8
Jordan
8
Lebanon
8
Saudi Arabia
7
Niger
7
Western Pacific Region
7
Venezuela
7
Togo
6
Egypt
6
Gambia
6
Burundi
6
Morocco
5
Libya
5
Sri Lanka
5
Iran
5
North America
5
Japan
5
Tunisia
5
Portugal
5
Mauritania
4
Papua New Guinea
4
Greece
4
Mexico
4
Chile
4
Albania
4
Laos
4
USA
3
Turkey
3
Malaysia
3
Peru
3
North Macedonia
3
Serbia
3
Ecuador
3
Palestine
3
Tajikistan
3
Moldova
3
Kyrgyzstan
3
Kazakhstan
3
Georgia
3
Gabon
3
Jamaica
3
Mauritius
3
Bosnia and Herzegovina
3
Argentina
2
Italy
2
Djibouti
2
Armenia
2
Canada
2
Qatar
2
Turkmenistan
2
France
2
Spain
2
Belarus
2
Israel
2
Vanuatu
1
Hungary
1
Croatia
1
Honduras
1
Cape Verde
1
Paraguay
1
Solomon Islands
1
Poland
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Romania
1
Denmark
1
Belgium
1
United Kingdom
1
Norway
1
Morocco
1
Azerbaijan
1
Eritrea
1
Authors & Publishers
Publication Years
Category
Countries
2076
Clinical Guidelines
536
Public Health
350
Women & Child Health
346
Key Resources
265
Capacity Building
122
Pharmacy & Technologies
68
Annual Report MEDBOX
2
General Guidelines
1
Protection & Security
1
Toolboxes
HIV
628
COVID-19
561
Mental Health
392
TB
353
Ebola
303
Planetary Health
273
Disability
259
Rapid Response
222
NTDs
192
AMR
163
Caregiver
143
Global Health Education
138
Conflict
121
NCDs
111
Refugee
104
Pharmacy
96
Health Financing Toolbox
91
Natural Hazards
55
Zika
45
Polio
43
Cholera
40
Social Ethics
23
Specific Hazards
17
Typhoon
3
South Sudan
2
Health Financing
1
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified ... care provider and do not receive the necessary care in a timely fashion. Without rapid detection of danger signs and access to effective treatment, including pre-referral treatment that can be administered in the community level, many of these children with severe malaria die.
In situations where there is no immediate access to a health care facility, WHO recommends the administration of a standard dose of an effective antimalarial medicine as pre-referral treatment before referral to a facility at which complete treatment can be administered.
Rectal artesunate is the WHO-recommended pre-referral intervention in situations where artesunate injection are not feasible for children under the age of 6 years with suspected severe malaria. The intervention reduces the risk of death or permanent disability by up to 50% provided the child is referred to a health facility at which complete treatment can be administered.
This field guide is aimed at supporting the effective deployment of RAS as pre-referral treatment of suspected severe malaria in line with the WHO malaria guidelines.
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providin...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at ....
It addresses the use of Diphtheria Antitoxin (DAT) in the treatment of diphtheria. There is a worldwide shortage of DAT and evidence based recommendations on the use of DAT were requested by many Member States.
The guidance also includes new recommendations on antibiotics. In patients with suspected or confirmed diphtheria, WHO recommends using macrolide antibiotics (azithromycin, erythromycin) rather than penicillin antibiotics.
This clinical practice guideline has been rapidly developed recognizing the global increase in diphtheria outbreaks. Outbreaks of diphtheria in Nigeria, Guinea and neighbouring countries in 2023 have highlighted the urgent need for evidence-based clinical practice guidelines for the treatment of diphtheria. Given the sporadic nature of outbreaks, many clinicians in the affected regions have never managed acute diphtheria and its related complications. Diphtheria remains a neglected disease and vaccination is the top priority. At the same time, for patients with diphtheria, access to antibiotics, DAT and supportive care can be lifesaving.
Small drinking-water supplies commonly experience operational, managerial, technical and resourcing challenges that impact their ability to deliver safe and reliable services. The needs and opportunities associated with these supplies therefore warrant explicit consideration in policies and regulati...
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental health treatments and progressi...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public ... problem, one of four priority noncommunicable diseases (NCDs) targeted for action by world leaders. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades.
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the .... Their drivers are social, environmental, commercial and genetic, and their presence is global. Every year 17 million people under the age of 70 die of NCDs, and 86% of them live in low- and middle-income countries (LMICs).
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the .... Their drivers are social, environmental, commercial and genetic, and their presence is global. Every year 17 million people under the age of 70 die of NCDs, and 86% of them live in low- and middle-income countries (LMICs).
World Health Organization. (2022). Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 4: developing an i...
The "Stories from the field" document by the WHO Regional Office for the Eastern Mediterranean shares effective strategies from the Eastern Mediterranean Region for addressing noncommunicable diseases (NCDs) and mental ... challenges, particularly during the COVID-19 pandemic. It highlights regional success stories in mitigating NCDs and mental health conditions through innovative, country-specific interventions. The report emphasizes multisectoral collaboration, community engagement, and resilience in public health responses. It aims to inspire further action and knowledge-sharing to enhance health outcomes in challenging settings across the region.
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on conside...
